These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7680867)

  • 1. How does the HIV escape cytotoxic T cell immunity?
    Phillips RE; McMichael AJ
    Chem Immunol; 1993; 56():150-64. PubMed ID: 7680867
    [No Abstract]   [Full Text] [Related]  

  • 2. Human immunodeficiency virus variants that escape cytotoxic T-cell recognition.
    Rowland-Jones SL; Phillips RE; Nixon DF; Gotch FM; Edwards JP; Ogunlesi AO; Elvin JG; Rothbard JA; Bangham CR; Rizza CR
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1353-4. PubMed ID: 1466955
    [No Abstract]   [Full Text] [Related]  

  • 3. HIV/AIDS. HLA leaves its footprints on HIV.
    McMichael A; Klenerman P
    Science; 2002 May; 296(5572):1410-1. PubMed ID: 12029119
    [No Abstract]   [Full Text] [Related]  

  • 4. Antigenic oscillations and shifting immunodominance in HIV-1 infections.
    Nowak MA; May RM; Phillips RE; Rowland-Jones S; Lalloo DG; McAdam S; Klenerman P; Köppe B; Sigmund K; Bangham CR
    Nature; 1995 Jun; 375(6532):606-11. PubMed ID: 7791879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined structural and immunological refinement of HIV-1 HLA-B8-restricted cytotoxic T lymphocyte epitopes.
    Goulder PJ; Reid SW; Price DA; O'Callaghan CA; McMichael AJ; Phillips RE; Jones EY
    Eur J Immunol; 1997 Jun; 27(6):1515-21. PubMed ID: 9209505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cell vaccination induces cross-reactive cytotoxic T lymphocytes specific for wild-type and natural variant human immunodeficiency virus type 1 epitopes in HLA-A*0201/Kb transgenic mice.
    Abdel-Motal UM; Friedline R; Poligone B; Pogue-Caley RR; Frelinger JA; Tisch R
    Clin Immunol; 2001 Oct; 101(1):51-8. PubMed ID: 11580226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New observations on cellular immune responses to HIV and T-cell epitopes.
    Gotch FM; Koup RA; Safrit JT
    AIDS; 1997; 11 Suppl A():S99-107. PubMed ID: 9451973
    [No Abstract]   [Full Text] [Related]  

  • 8. Designing and engineering of DNA-vaccine construction encoding multiple CTL-epitopes of major HIV-1 antigens.
    Bazhan SI; Belavin PA; Seregin SV; Danilyuk NK; Babkina IN; Karpenko LI; Nekrasova NA; Lebedev LR; Ignatyev GM; Agafonov AP; Poryvaeva VA; Aborneva IV; Ilyichev AA
    Vaccine; 2004 Apr; 22(13-14):1672-82. PubMed ID: 15068850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV T cell vaccines, the importance of clades.
    McMichael A; Mwau M; Hanke T
    Vaccine; 2002 May; 20(15):1918-21. PubMed ID: 11983245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diversity and variation in human immunodeficiency virus: implications for immune control.
    Ramsay AJ
    Immunol Cell Biol; 1992 Jun; 70 ( Pt 3)():215-21. PubMed ID: 1452223
    [No Abstract]   [Full Text] [Related]  

  • 11. Resistance of HIV-infected cells to cytotoxic T lymphocytes.
    Collins KL
    Microbes Infect; 2004 Apr; 6(5):494-500. PubMed ID: 15109965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic T lymphocyte lysis inhibited by viable HIV mutants.
    Meier UC; Klenerman P; Griffin P; James W; Köppe B; Larder B; McMichael A; Phillips R
    Science; 1995 Nov; 270(5240):1360-2. PubMed ID: 7481824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of HLA B8-restricted recognition by unrelated peptides: evidence for allosteric inhibition.
    Fernan A; Burrows SR; Moss DJ; Saul A; Suhrbier A
    Immunol Lett; 1991 Nov; 30(3):339-44. PubMed ID: 1724770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recognition of two overlapping CTL epitopes in HIV-1 p17 by CTL from a long-term nonprogressing HIV-1-infected individual.
    Harrer T; Harrer E; Barbosa P; Kaufmann F; Wagner R; Brüggemann S; Kalden JR; Feinberg M; Johnson RP; Buchbinder S; Walker BD
    J Immunol; 1998 Nov; 161(9):4875-81. PubMed ID: 9794421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of presentation of multiple HIV-1 cytotoxic T lymphocyte epitopes by HLA-B*3501 molecules that are associated with the accelerated progression of AIDS.
    Tomiyama H; Miwa K; Shiga H; Moore YI; Oka S; Iwamoto A; Kaneko Y; Takiguchi M
    J Immunol; 1997 May; 158(10):5026-34. PubMed ID: 9144523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strong memory CD8+ T cell responses against immunodominant and three new subdominant HLA-B27-restricted influenza A CTL epitopes following secondary infection of HLA-B27 transgenic mice.
    Cheuk E; Chamberlain JW
    Cell Immunol; 2005 Apr; 234(2):110-23. PubMed ID: 16054612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple transmissions of a stable human leucocyte antigen-B27 cytotoxic T-cell-escape strain of HIV-1 in The Netherlands.
    Cornelissen M; Hoogland FM; Back NK; Jurriaans S; Zorgdrager F; Bakker M; Brinkman K; Prins M; van der Kuyl AC
    AIDS; 2009 Jul; 23(12):1495-500. PubMed ID: 19487902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequence constraints and recognition by CTL of an HLA-B27-restricted HIV-1 gag epitope.
    Nietfield W; Bauer M; Fevrier M; Maier R; Holzwarth B; Frank R; Maier B; Riviere Y; Meyerhans A
    J Immunol; 1995 Mar; 154(5):2189-97. PubMed ID: 7868892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immune response to HIV: implications for vaccine development.
    Bolognesi DP
    Semin Immunol; 1993 Jun; 5(3):203-14. PubMed ID: 8347841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Papillomavirus virus-like particles can deliver defined CTL epitopes to the MHC class I pathway.
    Peng S; Frazer IH; Fernando GJ; Zhou J
    Virology; 1998 Jan; 240(1):147-57. PubMed ID: 9448699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.